US Stocks Edge Higher as Oil Prices Stage a Reversal Viatris Analyst Report Highlights Generic Drug Portfolio and Market Position CHAT vs XLK Performance and Fee TradeOffs for Tech Investors Nvidia and Asian Chip Giants Ride the AI Boom Generating Record Revenues HighFlying Stocks Resist Splits Which May Be Next to Crack AIGenerated Fake Evidence Scandal Korean Actor Kim Soohyuns Career Threatened Police Seek Arrest Warrant for YouTuber Janus Living Q1 2026 Earnings EPS Falls Short of Analyst Expectations Saratoga Investment Corp 8125 Notes due 2027 SAY Q1 2026 Earnings Steep EPS Miss Weighs on Sentiment Despite Modest Price Recovery Enova International Q1 2026 Earnings EPS Beats Estimates Stock Dips Slightly GALT Q1 2026 Earnings WiderThanExpected Loss as ClinicalStage Biotech Continues RD Spend DV Q1 2026 Earnings EPS Miss Weighs on Shares as Market Digests Profitability Pressure SAFE Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Oscar Health OSCR Gains Ground Breaking Through Key Technical Levels Tevogen Bio Holdings Warrant TVGNW Edges Higher in Thin Trading AtaiBeckley Inc ATAI Slips Slightly Amid Quiet Trading Hovers Near Key Support Erasca Inc ERAS Slides 315 as Biotech Sector Faces Pressure Key Levels to Watch Zions Bancorporation ZION Edges Higher as Regional Banking Sentiment Stabilizes Lands End to Unveil WHP Global Joint Venture Strategy on June 9 Micron Market Cap Surges Amid Trump Support and Wall Street Optimism A Closer Look at the TrillionDollar Claim Consumer Credit Growth Surges in December Implications for Economic Activity HS2s Cost Ballooning to 1027bn and Delays to 2039 Raise Fresh Questions Over UK Infrastructure Spending UK Universities Warn of Potential Cuts to Student Support Amid Persistent Funding Challenges MAS Complex Product Reforms Signal Shift to DisclosureBased Regulation USIran Talks Show Progress but Key Disagreements Persist on Uranium Enrichment and Strait of Hormuz Tolls Dominari Holdings Inc DOMH Q1 2024 Earnings Net Loss Per Share of 035 Amid Ongoing Portfolio Management Halozyme Therapeutics HALO Rises Modestly Support and Resistance Levels in Focus